19,237 followers
An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in myeloproliferative neoplasms: An overview of previous and ongoing studies with perspectives on the future https://t.co/QeevAvCAiD https://t.co/cw4Bzxn034